1. Home
  2. NXJ vs LXRX Comparison

NXJ vs LXRX Comparison

Compare NXJ & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen New Jersey Qualified Municipal Fund

NXJ

Nuveen New Jersey Qualified Municipal Fund

HOLD

Current Price

$12.39

Market Cap

503.5M

Sector

Finance

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$1.83

Market Cap

660.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXJ
LXRX
Founded
1999
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
503.5M
660.9M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
NXJ
LXRX
Price
$12.39
$1.83
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.15
AVG Volume (30 Days)
90.6K
2.3M
Earning Date
01-01-0001
05-12-2026
Dividend Yield
3.27%
N/A
EPS Growth
N/A
77.78
EPS
N/A
N/A
Revenue
N/A
$49,803,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
60.24
52 Week Low
$11.06
$0.49
52 Week High
$12.90
$1.86

Technical Indicators

Market Signals
Indicator
NXJ
LXRX
Relative Strength Index (RSI) 54.32 62.84
Support Level $11.94 $1.07
Resistance Level $12.76 N/A
Average True Range (ATR) 0.12 0.10
MACD 0.03 0.02
Stochastic Oscillator 80.34 86.25

Price Performance

Historical Comparison
NXJ
LXRX

About NXJ Nuveen New Jersey Qualified Municipal Fund

Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The company invests a majority of its managed assets in securities rated, at the time of investment, investment grade or, if the bonds are unrated, are judged by the manager to be of comparable quality.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: